Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
Yuru Wu,Qin Wan,Yong Xu,Jia Li,Ke Li,Zhihong Zhang,Qian Tang,Ying Miao,Pijun Yan
DOI: https://doi.org/10.2147/DMSO.S388330
2022-11-22
Abstract:Yuru Wu, 1– 4 Qin Wan, 1– 4 Yong Xu, 1– 4 Jia Li, 1– 4 Ke Li, 1– 4 Zhihong Zhang, 5 Qian Tang, 1– 4 Ying Miao, 1– 4 Pijun Yan 1– 4 1 Department of Endocrinology, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China; 2 Metabolic Vascular Disease Key Laboratory of Sichuan Province, Luzhou, Sichuan, People's Republic of China; 3 Sichuan Clinical Research Center for Nephropathy, Luzhou, Sichuan, People's Republic of China; 4 Cardiovascular and Metabolic Diseases Key Laboratory of Luzhou, Luzhou, People's Republic of China; 5 Department of General Medicine, the Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China Correspondence: Pijun Yan, Department of Endocrinology, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People's Republic of China, Tel/Fax +86-830-3165361, Email Objective: There is preliminary evidence that visceral fat area (VFA) was associated with the presence of type 2 diabetic peripheral neuropathy (DPN) in the Korean population; however, no studies have reported the association in Chinese population. The purpose of this study was to explore the possible correlation of VFA with DPN in such a population. Methods: A total of 2498 hospitalized patients with type 2 diabetes mellitus (T2DM) undergone VFA measurement, and were divided into DPN group (n=900) and non-DPN group (n=1594). The association of VFA with the presence of DPN was evaluated by correlation and multiple logistic regression analyses, generalized additive model with a smooth curve fitting, and receiver operating characteristic (ROC) curve analysis. Results: The VFA was significantly lower in the DPN group than in the non-DPN group (P < 0.001). VFA was significantly and positively associated with sural nerve conduction velocity (SNCV) and amplitude potential (SNAP) and negatively associated with the presence of DPN (all P< 0.001); there was no significant difference in the curve fitting (P = 0.344). Multivariate logistic regression analysis showed that the risk of presence of DPN decreased progressively across the VFA quartiles (P for trend < 0.001) and was significantly lower in patients in the highest VFA quartile than in those in the lowest quartile (OR: 0.382, 95% CI 0.151– 0.968, P< 0.001) after multivariate adjustment. The ROC analysis revealed that the best cut-off value of VFA for predicting the presence of DPN was 50.5cm 2 (sensitivity 84.40%; specificity 34.00%). Conclusion: These results suggest that lower VFA level may be associated with increased risk of the presence of DPN in T2DM patients. Keywords: visceral fat area, diabetic peripheral neuropathy, sural nerve conduction velocity, sural nerve amplitude potential, Chinese population Diabetic peripheral neuropathy (DPN) is one of the most common chronic diabetic complications characterized by demyelination and axonal degeneration, leading to reduction in quality of life, disability, enormous health care costs, and even death. 1,2 DPN may develop at the earliest stage of diabetes, and often progresses asymptomatically, without special and effective therapeutic strategies. Despite evidence that DPN may involve glucolipid metabolism disorders, insulin resistance (IR), inflammation, oxidative stress, and vascular dysfunction, 1 its pathogenesis is still not fully understood. Therefore, the identification of a novel modifiable risk factor for DPN in patients with type 2 diabetes mellitus (T2DM) is critical to facilitate early interventions aimed at improving such adverse health outcome and its economic consequences. Obesity, especially abdominal obesity, has been proven to be a potential risk factor for the development of diabetic macro- and microvascular complications, including DPN, 2–7 but the mechanisms underlying the associations are multifactorial and still unclear. It has been well established that visceral adipose tissue (VAT) can overproduce several bioactive pro-inflammatory cytokines and adipocytokines that lead to IR, metabolic disorders, chronic inflammation, oxidative stress, endothelial dysfunction, and atherosclerotic vascular damage, subsequently resulting in nerve ischemia and direct axonal injury. 5,8–11 Obesity is usually measured using several indicators such as body mass index (BMI), waist circumference (WC), waist-to-hip ratio, and body fat mass, however, these indicators are unable to accurately distinguish between VAT and subcutaneous adipose tissue. 12 At present, although magnetic resonance imaging (MRI) and computed tomography (CT -Abstract Truncated-
endocrinology & metabolism